Clinical trial for Opioid Use Disorder
Official title An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)
ClinicalTrials.gov ID: NCT06576323
What this study is testing
- What it's testing
- The study aims to create and test a plan for providing opioid treatment to mothers in the NICU. It wants to see if this approach is practical and acceptable for patients and staff.
- Who it's for
- The study is looking for mothers who are in the NICU with their newborns and have an opioid use disorder.
- What's involved
- Participants will take part in interviews to help design the treatment plan. The team will then test this plan in two NICUs to see how well it works.
- Time commitment
- The study involves interviews and the implementation of a new care plan in two partner NICUs, but the total duration is not specified.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Participants should be healthcare providers working within UPHS, who generally treat perinatal women or any individuals with OUD
- Participants should provide direct care to NICU patients and/or their mothers
- Participants should be proficient in English language
- Participants should be biological mothers of children hospitalized in the UPHS NICU for NAS
- See above for for interview participants.
You likely can't join if
- \- None
- \- None
- \- None
- \- Active suicidal ideation, or other severe psychopathology that must be addressed before effective MOUD can be prescribed
See the full eligibility criteria
- Participants should be healthcare providers working within UPHS, who generally treat perinatal women or any individuals with OUD
- Participants should provide direct care to NICU patients and/or their mothers
- Participants should be proficient in English language
- Participants should be biological mothers of children hospitalized in the UPHS NICU for NAS
- See above for for interview participants.
- Participants should be biological mothers of a child hospitalized in either of the two UPHS NICU for NAS (either HUP or PAH)
- Participants should be no more than 4 weeks postpartum
- Participants should have an Opioid Use Disorder than is currently untreated with medication assisted treatment or buprenorphine
- \- None
- \- None
- \- None
- \- Active suicidal ideation, or other severe psychopathology that must be addressed before effective MOUD can be prescribed
The study team makes the final eligibility decision.
Where it is enrolling
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.